HPB Surgery

HPB Surgery / 2016 / Article / Tab 1

Clinical Study

Hepatectomy Based on Future Liver Remnant Plasma Clearance Rate of Indocyanine Green

Table 1

Patient characteristics.


Age, years69 (38–86)
Sex, male, %67.3
HBs antigen+, %12.1
HCV antibody+, %14.0
ICGK0.151 (0.069–0.264)
ICGR15, %11.9 (1.9–35.4)
TLV, mL1181 (735–2169)
% RLV59.3 (34.7–93.7)
rICGK0.088 (0.050–0.199)
T-Bil, mg/dL0.7 (0.2–2.5)
Alb, g/dL3.9 (1.8–5.2)
Plt, 104/μL20.5 (8.3–72.0)
PT-INR1.03 (0.93–1.93)
eGFR (mL/min)76.0 (6.5–185.6)
Blood loss, mL867 (50–7750)
Operation time, min361 (151–748)

Indications for hepatectomy()

Hepatocellular carcinoma52
Metastatic liver tumor29

HBs antigen+: hepatitis B virus surface antigen positive, HCV antibody+: hepatitis C virus antibody positive, ICGR15: indocyanine green retention rate at 15 minutes, TLV: total liver volume, % RLV: remnant liver volume/total liver volume (%), T-Bil: total bilirubin, Alb: albumin, Plt: platelet count, PT-INR: international normalized ratio of prothrombin time, and eGFR: estimated glomerular filtration rate.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.